CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate…
Full results from REGEN-007 are being held and will be submitted to the American Society of Nephrology 2025 Kidney Week…
- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins- Series B round in planning to support…
Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries…
The Company's aim is to seek FDA consent to fast track the Clinical Development Program to treat Basal Cell Carcinoma…
AHMEDABAD, India, July 8, 2025 /PRNewswire/ -- Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in…
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on…
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage…
MIAMI, Fla., July 7, 2025 /PRNewswire/ -- Sitero, a leading provider of clinical and regulatory services, today announced that it…
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH,…